REGULATORY POWER: The Senate has approved an amendment sponsored by Sen. Mike Lee, R-Utah, to a budget resolution (S. Con.

BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts ...

Analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for Pacific Biosciences of California in a note issued to investors on Tuesday, February 18th. Cantor Fitzgerald analyst R. Osborn now ...